TWI300776B - Novel compounds - Google Patents
Novel compounds Download PDFInfo
- Publication number
- TWI300776B TWI300776B TW094140922A TW94140922A TWI300776B TW I300776 B TWI300776 B TW I300776B TW 094140922 A TW094140922 A TW 094140922A TW 94140922 A TW94140922 A TW 94140922A TW I300776 B TWI300776 B TW I300776B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- pyrrolidin
- pain
- benzamide
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0425766.3A GB0425766D0 (en) | 2004-11-23 | 2004-11-23 | Novel compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200626543A TW200626543A (en) | 2006-08-01 |
TWI300776B true TWI300776B (en) | 2008-09-11 |
Family
ID=33548739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094140922A TWI300776B (en) | 2004-11-23 | 2005-11-22 | Novel compounds |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1817281A1 (es) |
JP (1) | JP4233596B2 (es) |
KR (1) | KR100886294B1 (es) |
CN (1) | CN101065355A (es) |
AP (1) | AP2007004003A0 (es) |
AR (1) | AR052243A1 (es) |
AU (1) | AU2005308534A1 (es) |
BR (1) | BRPI0518486A2 (es) |
CA (1) | CA2589258A1 (es) |
CR (1) | CR9171A (es) |
EA (1) | EA011217B1 (es) |
GB (1) | GB0425766D0 (es) |
GT (1) | GT200500337A (es) |
IL (1) | IL183191A0 (es) |
MA (1) | MA29038B1 (es) |
MX (1) | MX2007006138A (es) |
NL (2) | NL1030485C2 (es) |
NO (1) | NO20072486L (es) |
PA (1) | PA8653501A1 (es) |
PE (1) | PE20061056A1 (es) |
SV (1) | SV2006002311A (es) |
TN (1) | TNSN07201A1 (es) |
TW (1) | TWI300776B (es) |
UY (1) | UY29224A1 (es) |
WO (1) | WO2006056884A1 (es) |
ZA (1) | ZA200703910B (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH628885A5 (en) * | 1978-01-01 | 1982-03-31 | Anphar Sa | Piperidine derivative |
AP2005003467A0 (en) * | 2003-06-17 | 2006-12-31 | Pfizer | N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline reuptake inhibitors. |
GB0314054D0 (en) * | 2003-06-17 | 2003-07-23 | Pfizer Ltd | Amide derivatives as selective serotonin re-uptake inhibitors |
-
2004
- 2004-11-23 GB GBGB0425766.3A patent/GB0425766D0/en not_active Ceased
-
2005
- 2005-11-18 KR KR1020077014351A patent/KR100886294B1/ko not_active IP Right Cessation
- 2005-11-18 CN CNA2005800401025A patent/CN101065355A/zh active Pending
- 2005-11-18 JP JP2007542360A patent/JP4233596B2/ja not_active Expired - Fee Related
- 2005-11-18 WO PCT/IB2005/003643 patent/WO2006056884A1/en active Application Filing
- 2005-11-18 MX MX2007006138A patent/MX2007006138A/es active IP Right Grant
- 2005-11-18 AP AP2007004003A patent/AP2007004003A0/xx unknown
- 2005-11-18 BR BRPI0518486-0A patent/BRPI0518486A2/pt not_active IP Right Cessation
- 2005-11-18 CA CA002589258A patent/CA2589258A1/en not_active Abandoned
- 2005-11-18 AU AU2005308534A patent/AU2005308534A1/en not_active Abandoned
- 2005-11-18 EP EP05808510A patent/EP1817281A1/en not_active Withdrawn
- 2005-11-18 EA EA200700920A patent/EA011217B1/ru not_active IP Right Cessation
- 2005-11-21 PE PE2005001362A patent/PE20061056A1/es not_active Application Discontinuation
- 2005-11-21 AR ARP050104866A patent/AR052243A1/es not_active Application Discontinuation
- 2005-11-22 NL NL1030485A patent/NL1030485C2/nl not_active IP Right Cessation
- 2005-11-22 TW TW094140922A patent/TWI300776B/zh active
- 2005-11-22 GT GT200500337A patent/GT200500337A/es unknown
- 2005-11-22 UY UY29224A patent/UY29224A1/es not_active Application Discontinuation
- 2005-11-23 SV SV2005002311A patent/SV2006002311A/es unknown
- 2005-11-23 PA PA20058653501A patent/PA8653501A1/es unknown
-
2006
- 2006-10-27 NL NL1032760A patent/NL1032760C2/nl not_active IP Right Cessation
-
2007
- 2007-05-14 IL IL183191A patent/IL183191A0/en unknown
- 2007-05-15 ZA ZA200703910A patent/ZA200703910B/xx unknown
- 2007-05-15 NO NO20072486A patent/NO20072486L/no not_active Application Discontinuation
- 2007-05-22 TN TNP2007000201A patent/TNSN07201A1/fr unknown
- 2007-05-23 MA MA29935A patent/MA29038B1/fr unknown
- 2007-06-07 CR CR9171A patent/CR9171A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20070086599A (ko) | 2007-08-27 |
EA011217B1 (ru) | 2009-02-27 |
NO20072486L (no) | 2007-06-20 |
AU2005308534A1 (en) | 2006-06-01 |
AP2007004003A0 (en) | 2007-06-30 |
GB0425766D0 (en) | 2004-12-22 |
KR100886294B1 (ko) | 2009-03-04 |
BRPI0518486A2 (pt) | 2008-11-18 |
CN101065355A (zh) | 2007-10-31 |
ZA200703910B (en) | 2008-09-25 |
TNSN07201A1 (fr) | 2008-11-21 |
GT200500337A (es) | 2006-06-13 |
PA8653501A1 (es) | 2006-06-02 |
CR9171A (es) | 2007-07-04 |
WO2006056884A1 (en) | 2006-06-01 |
JP2008520646A (ja) | 2008-06-19 |
UY29224A1 (es) | 2006-06-30 |
JP4233596B2 (ja) | 2009-03-04 |
EP1817281A1 (en) | 2007-08-15 |
TW200626543A (en) | 2006-08-01 |
EA200700920A1 (ru) | 2007-12-28 |
NL1032760A1 (nl) | 2006-12-13 |
NL1030485C2 (nl) | 2006-11-07 |
NL1030485A1 (nl) | 2006-05-24 |
NL1032760C2 (nl) | 2007-04-17 |
AR052243A1 (es) | 2007-03-07 |
CA2589258A1 (en) | 2006-06-01 |
IL183191A0 (en) | 2007-08-19 |
MX2007006138A (es) | 2007-07-19 |
MA29038B1 (fr) | 2007-11-01 |
SV2006002311A (es) | 2006-09-14 |
PE20061056A1 (es) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200914431A (en) | Novel morpholine compounds | |
KR20010021853A (ko) | 카파 효능제 화합물, 약제학적 제형 및 이를 이용한소양증의 예방 및 치료 방법 | |
US7122683B2 (en) | Amides useful as monoamine re-uptake inhibitors | |
JP2008543828A (ja) | ドーパミン作動薬としての3−フェニルアゼチジン誘導体 | |
JP2002524444A (ja) | κアゴニスト化合物およびその薬学的製剤 | |
TW200819132A (en) | Piperidine, morpholine, and pyrrolidinyl analogs | |
TW201008912A (en) | 3-(phenoxyphenylmethyl)pyrrolidine compounds | |
CN101600701A (zh) | 芳基磺酰胺衍生物和其使用方法 | |
TW201710248A (zh) | 做為nr2b nmda受體拮抗劑之3,3-二氟哌啶胺基甲酸酯雜環化合物 | |
US7619096B2 (en) | 3-Aminopyrrolidines as inhibitors of monoamine uptake | |
RU2320369C2 (ru) | Комбинации, содержащие альфа-2-дельта лиганды и ингибиторы обратного захвата серотонина/норадреналина | |
JP4157158B2 (ja) | ドーパミン作動薬の新規な塩の形態 | |
TWI300776B (en) | Novel compounds | |
JP2008524200A (ja) | 新規化合物 | |
US20070066604A1 (en) | Diaminoalcohols as therapeutic compounds | |
JP2008523137A (ja) | セロトニンおよびノルアドレナリン再取込み阻害剤としてのn−ピロリジン−3−イル−アミド誘導体 | |
US20090239929A1 (en) | N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors | |
JP2008521789A (ja) | クロマン化合物 | |
TW201041581A (en) | N-[(7-azabicyclo[2.2.1]hept-1-yl)-aryl-methyl] benzamide derivatives, preparation thereof and therapeutic use thereof | |
WO1997046515A1 (fr) | Benzenes substitues ne presentant pas d'effets inhibiteurs | |
JP2007314534A (ja) | 医薬および動物薬として適切な塩 | |
TW201014592A (en) | Benzamide derivatives, preparing method and medicinal use thereof |